Clinical Trial Update: Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)

View source ↗

Summary

The document reports completion of a clinical trial investigating magnetic resonance spectroscopy biomarkers of tumor metabolism with MK-0000-145 in glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• MK-0000-145

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glioma | Status: COMPLETED